Spots Global Cancer Trial Database for stage ii pancreatic cancer ajcc v8

Every month we try and update this database with for stage ii pancreatic cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer	NCT03816358	Pancreatic Aden... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	Anetumab Ravtan... Biopsy Biospecimen Col... Gemcitabine Hyd... Ipilimumab Nivolumab	18 Years -	National Cancer Institute (NCI)
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer	NCT05911243	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	Acupressure The... Best Practice Biospecimen Col... Questionnaire A...	18 Years - 65 Years	University of Washington
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer	NCT04887805	Advanced Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Lenvatinib Mesy... Pembrolizumab	18 Years -	City of Hope Medical Center
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer	NCT06381154	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin	18 Years -	Mayo Clinic
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer	NCT03816358	Pancreatic Aden... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	Anetumab Ravtan... Biopsy Biospecimen Col... Gemcitabine Hyd... Ipilimumab Nivolumab	18 Years -	National Cancer Institute (NCI)
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas	NCT05053971	Advanced Lympho... Advanced Malign... Advanced Pancre... B-Cell Non-Hodg... Metastatic Panc... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	BET Bromodomain... Core Biopsy Entinostat	18 Years -	National Cancer Institute (NCI)
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer	NCT02983578	Advanced Colore... Advanced Lung N... Lung Non-Small ... Mismatch Repair... Refractory Colo... Refractory Lung... Refractory Panc... Stage II Pancre... Stage III Color... Stage III Lung ... Stage III Pancr... Stage IIIA Colo... Stage IIIA Lung... Stage IIIB Colo... Stage IIIB Lung... Stage IIIC Colo... Stage IIIC Lung... Stage IV Colore... Stage IV Lung C... Stage IV Pancre... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color...	Danvatirsen Durvalumab	18 Years -	M.D. Anderson Cancer Center
Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas	NCT03925428	Advanced Lympho... Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Entinostat Molibresib	12 Years -	National Cancer Institute (NCI)
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma	NCT06206876	Advanced Pancre... Locally Advance... Metastatic Panc... Refractory Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Biopsy Biospecimen Col... Computed Tomogr... DDX5 Degrader F... Magnetic Resona...	18 Years -	Roswell Park Cancer Institute
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma	NCT06398587	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Onvansertib Gemcitabine Nab-paclitaxel Electrocardiogr... Magnetic Resona... Positron Emissi... Biospecimen Col... Biospecimen Col... Computed Tomogr...	18 Years -	OHSU Knight Cancer Institute
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer	NCT04821284	Locally Advance... Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Gemcitabine Hyd... Nab-paclitaxel Fluorouracil Irinotecan Hydr... Leucovorin Calc... Oxaliplatin Perflubutane Mi... Contrast-Enhanc... Quality-of-Life... Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer	NCT05911243	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Stage II Pancre... Stage III Pancr... Stage IV Pancre...	Acupressure The... Best Practice Biospecimen Col... Questionnaire A...	18 Years - 65 Years	University of Washington
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors	NCT04616534	Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine	18 Years -	National Cancer Institute (NCI)
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	NCT05733000	Advanced Biliar... Advanced Colore... Advanced Gastro... Advanced Lung A... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Urothe... Clinical Stage ... Clinical Stage ... Metastatic Bili... Metastatic Colo... Metastatic Gast... Metastatic Lung... Metastatic Ovar... Metastatic Panc... Metastatic Urot... Refractory Bili... Refractory Colo... Refractory Gast... Refractory Lung... Refractory Ovar... Refractory Panc... Refractory Urot... Stage II Pancre... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Pancr... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Pancre...	Biospecimen Col... Computed Tomogr... Devimistat Fluorouracil Gemcitabine Hyd... Hydroxychloroqu... Magnetic Resona...	18 Years -	Northwestern University
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors	NCT03784677	Advanced Malign... Refractory Mali... Refractory Ovar... Refractory Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Ovari... Stage IVA Prost... Stage IVB Ovari... Stage IVB Prost...	TRPV6 Calcium C...	18 Years -	M.D. Anderson Cancer Center
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study	NCT04449679	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Stage 0 Colorec... Stage 0 Pancrea... Stage I Colorec... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Colore... Stage II Pancre... Stage IIA Color... Stage IIA Pancr... Stage IIB Color... Stage IIB Pancr... Stage IIC Color... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVB Color... Stage IVC Color...	Patient Monitor... Questionnaire A... Consultation	18 Years -	Thomas Jefferson University
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors	NCT04616534	Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine	18 Years -	National Cancer Institute (NCI)
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer	NCT04887805	Advanced Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Lenvatinib Mesy... Pembrolizumab	18 Years -	City of Hope Medical Center
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer	NCT05034627	Locally Advance... Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre...	Biopsy Calaspargase Pe... Cobimetinib	18 Years -	OHSU Knight Cancer Institute
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer	NCT03432676	ATM Gene Mutati... Deleterious BRC... Deleterious BRC... Homologous Reco... Pancreatic Duct... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre...	Epacadostat Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)	NCT04106856	Borderline Rese... Locally Advance... Locally Advance... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	Hypofractionate... Losartan Losartan Potass... Quality-of-Life... Questionnaire A...	18 Years -	University of Utah
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer	NCT04821284	Locally Advance... Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Gemcitabine Hyd... Nab-paclitaxel Fluorouracil Irinotecan Hydr... Leucovorin Calc... Oxaliplatin Perflubutane Mi... Contrast-Enhanc... Quality-of-Life... Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors	NCT04616534	Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine	18 Years -	National Cancer Institute (NCI)
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic Cancer	NCT04172532	Locally Advance... Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa...	Biopsy Biospecimen Col... Computed Tomogr... Hypofractionate... Magnetic Resona... Peposertib Placebo Adminis...	18 Years -	National Cancer Institute (NCI)
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer	NCT06423326	Borderline Rese... Resectable Panc... Stage I Pancrea... Stage II Pancre... Stage III Pancr...	Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nab-paclitaxel Pancreatic Surg...	18 Years -	Emory University
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer	NCT05055323	Resectable Panc... Stage 0 Pancrea... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr...	Pyrvinium Pamoa...	18 Years -	Thomas Jefferson University
Targeted Pathway Inhibition in Patients With Pancreatic Cancer	NCT04005690	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Cobimetinib Olaparib Onvansertib Azenosertib	18 Years -	OHSU Knight Cancer Institute
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer	NCT06381154	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin	18 Years -	Mayo Clinic
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer	NCT06423326	Borderline Rese... Resectable Panc... Stage I Pancrea... Stage II Pancre... Stage III Pancr...	Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nab-paclitaxel Pancreatic Surg...	18 Years -	Emory University
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations	NCT04550494	Advanced Pancre... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HER2-Positive B... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Brea... Metastatic Gast... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Pros... Platinum-Sensit... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Talazoparib	18 Years -	National Cancer Institute (NCI)
SMMART Adaptive Clinical Treatment (ACT) Trial	NCT05238831	Advanced Breast... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Prosta... Advanced Sarcom... Anatomic Stage ... Anatomic Stage ... Recurrent Adult... Recurrent Breas... Recurrent Ovari... Recurrent Prost... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage IV Ovaria... Stage IV Pancre...	Alectinib Alpelisib Anastrozole Atezolizumab Bevacizumab Biopsy Biospecimen Col... Capecitabine Carboplatin Cobimetinib Entrectinib Eribulin Fulvestrant Hyaluronidase-z... Irinotecan Letrozole Nab-paclitaxel Niraparib Olaparib Paclitaxel Palbociclib Pertuzumab Quality-of-Life... Trastuzumab Trastuzumab Emt... Vemurafenib Vinorelbine Vismodegib	18 Years -	OHSU Knight Cancer Institute
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study	NCT03033225	Advanced Pancre... Locally Advance... Metastatic Panc... Pancreatic Neop... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Endoscopic Ultr... Fluorescence Im... Photodynamic Th... Quality-of-Life... Questionnaire A... Verteporfin	18 Years -	Mayo Clinic
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma	NCT06398587	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Onvansertib Gemcitabine Nab-paclitaxel Electrocardiogr... Magnetic Resona... Positron Emissi... Biospecimen Col... Biospecimen Col... Computed Tomogr...	18 Years -	OHSU Knight Cancer Institute
Targeted Pathway Inhibition in Patients With Pancreatic Cancer	NCT04005690	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Cobimetinib Olaparib Onvansertib Azenosertib	18 Years -	OHSU Knight Cancer Institute
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer	NCT05411094	Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Durvalumab Olaparib Radiation Thera...	18 Years -	National Cancer Institute (NCI)
Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas	NCT03925428	Advanced Lympho... Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Entinostat Molibresib	12 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: